- Home
- ANTX vs VBF Comparison
ANTX vs VBF Comparison
Compare ANTX & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.58
Company Overview
Basic Information| Metric | ANTX | VBF |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 165.5M |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ANTX | VBF |
|---|---|---|
| Price | $3.58 | $14.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 296.8K | 56.5K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $14.03 |
| 52 Week High | $7.19 | $15.86 |
Technical Indicators
Market Signals| Indicator | ANTX | VBF |
|---|---|---|
| Relative Strength Index (RSI) | 30.50 | 56.39 |
| Support Level | $3.21 | $14.04 |
| Resistance Level | $5.15 | $14.79 |
| Average True Range (ATR) | 0.31 | 0.29 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 19.73 | 64.19 |
Price Performance
Historical Comparison ANTX
VBF
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.